Copper and Zinc Metal-Organic Frameworks with Bipyrazole Linkers Display Strong Antibacterial Activity against Both Gram+ and Gram- Bacterial Strains

Molecules. 2023 Aug 21;28(16):6160. doi: 10.3390/molecules28166160.

Abstract

Here, we report a new synthetic protocol based on microwave-assisted synthesis (MAS) for the preparation of higher yields of zinc and copper in MOFs based on different bis(pyrazolyl)-tagged ligands ([M(BPZ)]n where M = Zn(II), Cu(II), H2BPZ = 4,4'-bipyrazole, [M(BPZ-NH2)]n where M = Zn(II), Cu(II); H2BPZ-NH2 = 3-amino-4,4'-bipyrazole, and [Mx(Me4BPZPh)] where M = Zn(II), x = 1; Cu(II), x = 2; H2Me4BPZPh = bis-4'-(3',5'-dimethyl)-pyrazolylbenzene) and, for the first time, a detailed study of their antibacterial activity, tested against Gram-negative (E. coli) and Gram-positive (S. aureus) bacteria, as representative agents of infections. The results show that all MOFs exert a broad-spectrum activity and strong efficiency in bacterial growth inhibition, with a mechanism of action based on the surface contact of MOF particles with bacterial cells through the so-called "chelation effect" and reactive oxygen species (ROS) generation, without a significant release of Zn(II) and Cu(II) ions. In addition, morphological changes were elucidated by using a scanning electron microscope (SEM) and bacterial cell damage was further confirmed by a confocal laser scanning microscopy (CLSM) test.

Keywords: Cu(II) and Zn(II) MOFs; ROS generation; antibacterial activity; bis(pyrazolate) ligands; chelation theory.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacteria
  • Copper* / pharmacology
  • Escherichia coli
  • Metal-Organic Frameworks*
  • Staphylococcus aureus
  • Zinc / pharmacology

Substances

  • Copper
  • Metal-Organic Frameworks
  • Zinc
  • Anti-Bacterial Agents

Grants and funding

This research was supported by the project Nano4-Fresh—Nanomaterials for an environmentally friendly and sustainable handling of perishable products (PRIMA19_00246), which is part of the Partnership on Research and Innovation in the Mediterranean Area (PRIMA) Programme supported by the European Union and funded by the national funding bodies of Participating States, in our case financed by Italian Ministry of University and Research (MUR).